Serological diagnosis of tuberculosis

Area of Science:

• Immunology
• Infectious Diseases
• Medical Diagnostics

Background:

• Tuberculosis diagnosis often relies on sputum smear microscopy, which can be unhelpful in certain cases.
• There is a long-standing need for sensitive and specific serological tests for tuberculosis (TB).
• Recent advancements in reagents, including purified antigens and monoclonal antibodies, have improved TB serological test performance.

Purpose of the Study:

• To review developments in serological tests for tuberculosis over the past decade.
• To evaluate the potential of new reagents for TB diagnosis and monitoring.
• To identify promising antigens and antibody assays for various TB forms.

Main Methods:

• Review of recent literature on tuberculosis serological tests.
• Evaluation of purified antigens (e.g., antigen 5, 16 kDa antigen) and monoclonal antibody assays.
• Analysis of antibody levels in different TB disease stages (primary vs. post-primary) and in HIV-related TB.

Main Results:

• Antigen 5 (38 kDa) shows potential as a screening reagent for infectious TB.
• The 16 kDa antigen may be useful for monitoring treatment compliance.
• A monoclonal antibody competition assay targeting the anti-38 kDa antibody demonstrates high sensitivity for smear-negative TB.
• Serological tests for HIV-related TB have been disappointing.
• Antibody profiles differ between primary and post-primary TB.

Conclusions:

• New serological reagents offer sensitivity and specificity comparable to existing diagnostic methods.
• Specific antigens and assays show promise for diagnosing infectious TB and monitoring treatment.
• Further research is required to determine optimal antigen combinations for accurate tuberculosis serodiagnosis.
• Tests for tuberculous meningitis require further clinical evaluation.